To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
In response to the sustained decline in academic psychiatry posts and infrastructure across the UK, the Royal College of Psychiatrists’ Academic Strategy proposes seven strategic pillars to rebuild workforce capacity through collaboration and innovation, and argues for revitalising the discipline that is essential for scientific leadership, excellence and mental healthcare.
Depression exhibits significant heterogeneity in its genetic underpinnings. The role of genetic components in the development of depression and its comorbidities remains insufficiently explored.
Methods
First, depression risk loci from a large-scale genome-wide meta-analysis were annotated to Gene Ontology (GO) terms by functional enrichment. GO-based polygenic risk scores (GO-PRS) were then calculated for individuals in the UK Biobank. Principal component analysis (PCA) was applied for dimensionality reduction, followed by cluster analysis to identify genetic subtypes of depression. Multistate models were applied to assess the impact of genetic patterns on the trajectory from healthy status to incident depression, and depression to 26 subsequent diseases, as well as the associations between environmental factors and disease trajectories across genetic subtypes.
Results
Participants were categorized into three genetic subtypes: immune-dominant, neuro-dominant, and comprehensive-risk. Significant differences in risk of depression and subsequent diseases, and susceptibility to environmental factors were observed across subtypes. Comprehensive-risk subtype showed higher risks of depression compared to immune-dominant (HR: 1.10, 95% CI: 1.05–1.15) and neuro-dominant subtype (HR: 1.12, 95% CI: 1.08–1.16). Comprehensive-risk subtype exhibited higher risks of transition from depression to subsequent diseases, such as anemia compared to immune-dominant subtype, and diseases of the digestive system compared to neuro-dominant subtype. Environmental factors were more strongly associated with the transition from depression to subsequent diseases in immune-dominant and comprehensive-risk subtypes, including cardiovascular, respiratory, and metabolic diseases.
Conclusions
Our findings highlight the genetic heterogeneity of depression and comorbidities, and shed light on how genetic components modulate responses to environmental factors.
Anxiety disorders show striking sex differences in prevalence, symptoms, and clinical characteristics, shaping how they manifest and are experienced.
Methods
Here, we report the first sex-specific meta-analysis of genome-wide association studies (GWAS) of anxiety, leveraging two of the largest biobank datasets, UK Biobank and All of Us, comprising 85,042 female cases with 196,789 controls and 36,732 male cases with 136,924 controls. Functional annotation, sex-specific polygenic scores (PGS), and genetic correlations were performed to assess genetic differences and functional implications.
Results
In females, 21 lead SNPs were significantly associated with anxiety, compared to five in males. Although the genetic correlation between sexes was high, it was significantly different from one, indicating partially distinct genetic architectures. In addition, both the SNP-based observed and liability-scale heritabilities (assuming a 2:1 female-to-male prevalence ratio) were significantly higher in females. Gene-based tests and functional prioritization identified different genes associated with anxiety in females and males. Moreover, genetic correlation analyses revealed stronger associations of female anxiety with attention-deficit/hyperactivity disorder (ADHD) and body mass index (BMI), whereas male anxiety showed stronger correlations with waist-hip-ratio-adjusted BMI.
Conclusions
While the overall genetic architecture of anxiety is largely shared, our findings reveal distinct sex-specific genetic associations and correlations, highlighting the value of analyzing the sexes separately to uncover genetic signals that may be masked in sex-combined samples.
This chapter includes the diagnosis of T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) and measurable disease detection (MRD) post therapy. Flow cytometry immunophenotyping is essential in establishing a diagnosis of T-ALL/LBL and subclassifying by their maturation into early T-phenotype (ETP), near ETP, cortical thymic T-, and mature T-ALL/LBL. Recent advancement in genetic classifications of T-ALL/LBL shows high-risk genetic alterations are highly associated with ETP-ALL. T-ALL/LBL show overlap features with acute undifferentiated leukemia, mixed phenotype T/myeloid, T/B leukemia, indolent T-lymphoblastic proliferation, and mature T-cell lymphoma/leukemia. The features pertinent for differential diagnosis are illustrated. For MRD, the discussion includes the principles and strategies, analysis and interpretations, mimics and common pitfalls. The pros and cons of flow cytometry MRD are compared with molecular MRD, including NGS sequencing (Clonoseq). Although currently there is no FDA-approved CAR T-therapy for T-ALL, promising products such as CD7-CAR and CD5-CAR have been used in clinical trials. Strategies in MRD and challenges in the era of targeted therapy are discussed.
We explore the ongoing new great wave of innovation, explaining its origin and purpose. We show with substantial empirical evidence that the current great wave of innovation will unlock the bottlenecks of productivity growth by solving problems in reducing the health burden of an ageing population, simplifying global supply chains and getting rid of our current inefficient use of energy. These three aspects will together unlock enormous economic potential. This is what we call ‘smartification’ of the economy, where, notably, the low-carbon transition has a key role in enabling future growth.
The Swedish Twin Registry (STR), established in the late 1950s, is one of the world’s most comprehensive twin registries and a cornerstone for research on genetic and environmental determinants of health. STR includes data on Swedish-born twins since 1886, complemented by longitudinal questionnaires, clinical measures, and biobank samples. In 2019, STR became a national research infrastructure with a mission to provide broader data sharing, while in 2025, STR further transitioned into a legally defined role as a ‘certain research database’ under the new Swedish Act on Certain Research Databases. The new legislation provides a framework for collecting and storing personal data with broad consent for future research projects, without requiring ethical approval for the data collection per se. Instead, ethical review is conducted separately for each research project seeking to use STR data. This article aims to describe STR’s current role, governance, and legal context, highlighting implications for data access and biobank integration. The registry currently holds data on more than 160,000 twins, with ongoing ascertainment at 9 months and 9 years with follow-ups at ages 15, 18, and 24. Annual linkages to national health registers enrich longitudinal analyses of disease outcomes. A variable search engine is openly available via STR’s web portal while higher level metadata is provided through Swedish research data services. STR’s evolution illustrates both opportunities and challenges in balancing open science practices, legal compliance, and participant integrity within large-scale research infrastructures.
Maize is the most important staple food in sub-Saharan Africa. Yet, smallholders produce on average about 20% of what is possible with best agronomic practices. On-farm experiments were conducted over two consecutive cropping seasons in Central Mozambique to investigate the contribution of genotype-by-environment-by-management interactions to maize yields in relation to improved cultivars, sowing time, and fertilization regimes across soil fertility conditions. In 2022–2023, maize yield variability on high-fertility fields was explained by a three-way interaction between fertilizer regime, sowing date, and cultivar, whereas on low-fertility fields, it was explained by fertilizer regime only. The highest yields were observed with early sowing of an intermediate (3.6 t ha−1) or early (3.1 t ha−1) maturity cultivar, whereas late sowing yielded the least (1.6 t ha−1). In 2023–2024, characterized by a severe El Niño drought, yield variability was explained by cultivar on high-fertility fields (with the intermediate maturity cultivar yielding highest) and by fertilizer regime on low-fertility fields. Results from farmer-managed experiments conducted in the same season confirmed the importance of cultivar choice and fertilizer use. Profitability with improved maize cultivars and mineral fertilizers depended on soil fertility and on the extent of water limitations to maize growth, with trade-offs arising between food security and return on investment when improved genetics and agronomic management were used. Targeting intermediate maturity maize cultivars with early sowing and fertilizer inputs was found to be critical to improve food security amid climate change.
What are the key design elements of human language? How does it work? What makes it different from how animals communicate and convey information? How did it evolve, biologically speaking? In what respects do animals fail to do what we humans do so effortlessly? Language is a uniquely human trait, but without a degree in linguistics, it is difficult to comprehend how it works. This fascinating book addresses these and related questions in a lively and engaging way, and demonstrates the 'nuts and bolts' of how language actually works. Readers are introduced to key discoveries in the study of language, such as Chomsky's ideas about 'language faculty', and parallels are drawn with well-known issues in science, such as 'flat earth', the nature-nurture debate, and the teaching of language to apes. Language – something so universal to all human experience – is a fascinating cognitive system, and this book explains how, and why.
Cognitive reserve (CR) is a protective factor in first-episode psychosis (FEP), influencing cognitive, clinical, and functional outcomes. CR is shaped by a combination of genetic, clinical, and environmental factors, yet the extent of their respective contributions remains unclear. This study investigates the influence of polygenic risk scores (PRS), clinical and environmental variables on CR in FEP.
Methods
A cohort of 174 individuals with non-affective FEP, aged 25.5 (SD=5.3), was analyzed. CR was assessed using a socio-behavioral proxy. PRS for educational attainment (PRSEA), intelligence (PRSIQ), cognitive performance (PRSCP), occupational attainment (PRSOA), physical activity (PRSPA), and schizophrenia (PRSSZ) were calculated. Age at onset, socioeconomic status, birth weight, and family history of psychosis were considered. Multiple regression models were employed to evaluate the impact of the different predictors on CR.
Results
PRSEA (p=0.002), age at onset (p=5.32x10-5), and family history of psychosis (p=0.001) emerged as the strongest contributors to CR. Higher PRSEA was associated with higher levels of CR, while earlier age at onset and positive family history were associated with lower CR. The model incorporating environmental, clinical, and genetic variables explained 17.7% of the variance in CR, and the one without PRS explained 13.5%. The inclusion of PRSEA in the model improved the explanatory power (Δadj.R2=0.042) and predictive accuracy (ΔRMSE=−0.288).
Conclusions
These findings highlight the role of precision psychiatry in better understanding CR. Early identification of individuals with earlier onset, family history of psychosis, and lower genetic predisposition to educational attainment may help characterize those with lower CR.
Rare copy number variants (CNVs; deleted/duplicated DNA segments) are associated with childhood attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). It is unknown whether carrying a CNV moderates the effect of ADHD/ASD on adult outcomes. In a UK population-based cohort, the Avon Longitudinal Study of Parents and Children, ADHD and ASD difficulties at ages 7–16 years were defined categorically. Outcomes included: General Certificate of Secondary Education non-attainment; depression at ages 18 and 24; functioning at age 25; not in education, employment or training; and receiving state benefits at age 25. Logistic regressions were used to assess associations between ADHD/ASD and outcomes, and to test CNVs as moderators. Multiple imputation was used to account for data missingness. We did not find strong evidence of CNVs moderating the effect of ADHD or ASD on young adult outcomes. However, confidence intervals for the moderating effect were wide, so further research in larger clinical samples is necessary.
Major depressive disorder (MDD), smoking, and drinking frequently co-occur, with evidence suggesting these relationships may differ by sex. However, the direction of causality and the extent of sex-specific associations remain unclear. We investigated sex-specific genetic relationships between MDD and substance use phenotypes using genome-wide association studies (GWAS) from the UK Biobank and publicly available sex-stratified GWAS for MDD and problematic alcohol use (PAU). Causal effects were assessed using bidirectional, sex-stratified Mendelian randomization (MR). We further applied multivariable MR (MVMR) to evaluate the influence of socioeconomic status (SES). Genetic correlation analyses indicated significant shared genetic architecture between MDD and all substance use traits in sex-combined GWAS. In sex-specific analyses, the correlation between cigarettes per day and MDD was significantly stronger in females, and drinks per week were correlated with MDD only in females. MR analyses showed that genetic liability to MDD increased the risk of smoking initiation and PAU in females, and was associated with reduced alcohol drinking frequency in males. In contrast, no tested substance use trait showed evidence of a causal effect on MDD in either sex. MVMR adjusting for SES attenuated the association between MDD and smoking initiation. The effect on PAU in females remained. In males, the negative association between MDD and drinking frequency became non-significant after SES adjustment. These findings reveal sex-specific genetic and causal relationships between smoking, drinking, and MDD, and highlight the role of SES as a potential confounder. Incorporating sex and socioeconomic context is critical when examining these associations.
Childhood-onset cardiomyopathies are rare and not well characterised. This study aimed to describe the clinical features of a paediatric cohort with primary cardiomyopathies, with a particular focus on aetiology and both short- and long-term outcomes.
Materials and Methods:
A retrospective descriptive study was conducted, including patients diagnosed with primary cardiomyopathies before the age of 18. Clinical presentation, aetiology, and outcomes were analysed for each morphological subtype of cardiomyopathy.
Results:
A total of 76 patients met the inclusion criteria. Dilated cardiomyopathy was the most common subtype (48.6%), followed by hypertrophic (31.5%), left ventricular non-compaction (10.5%), restrictive (5.2%), and arrhythmogenic cardiomyopathy (3.9%). The mean age at diagnosis was 6.3 ± 5.6 years, with a slight female predominance (56.6%). The rate of genetic diagnosis was 25.6%; the most commonly identified pathogenic or likely pathogenic variants were in MYH7, FLNC, TTN, and MYBPC3, across different morphological subtypes. A total of 94.7% of patients received at least one cardiovascular medication, and 9.2% received intracardiac devices. The overall mortality rate was 22.3%, and the heart transplant rate was 15.7%.
Conclusions:
These findings highlight the heterogeneous aetiology of paediatric cardiomyopathies and the variability in outcomes according to morphological, genetic, and clinical subtypes. The results underscore the importance of individualised evaluation and management for affected patients.
17p13.3 microdeletions involving deletion of the gene YWHAE are a newly recognised cause of neurodevelopmental disorder. There are now emerging case reports of this genetic disorder associated with CHDs, and this case report outlines the first instance of this specific 17p13.3 microdeletion with pulmonary atresia with ventricular septal defect.
This undergraduate biological psychology textbook offers a critical introduction to brain and behavior. Psychology lectures open with 'the brain is the most complex and mysterious object in the universe', only to quickly reduce that complexity by teaching simplified models. This textbook challenges these narratives by focusing on the latest neurotechnological advances, to clarify the limits of current models, and to inspire the development of safe and accessible technologies for human use. Its central aim is to promote critical thinking and inspire students to pose novel research questions that build from current advances. It is an ideal textbook for instructors who are eager to push beyond a conventional introductory curriculum. Beautifully illustrated and full of practical applications, it is accompanied by teaching slides and a test bank.
Large biobanks offer unprecedented data for psychiatric genomic research, but concerns exist about representativeness and generalizability. This study examined depression prevalence and polygenic risk score (PRS) associations in the All of Us data to assess potential impacts of nonrepresentative sampling.
Methods
Depression prevalence and correlates were analyzed in two subsamples: those with self-reported personal medical history (PMH) data (N = 185,232 overall; N = 114,739 with genetic data) and those with electronic health record (EHR) data (N = 287,015 overall; N = 206,175 with genetic data). PRS weights were estimated across ancestry groups. Associations of PRS with depression were examined by state and ancestry.
Results
Depression prevalence varied across states in both PMH (16.7–35.9%) and EHR (0.2–45.8%) data. Concordance between PMH and EHR diagnoses was low (kappa: 0.29, 95% CI: 0.30–0.30). Overall, one standard deviation increase in depression PRS was associated with lifetime depression based on PMH (odds ratio [OR] = 1.05, 95% confidence interval [CI]: 1.04–1.07) and EHR (OR = 1.05, 95% CI: 1.04–1.07). Results were generally consistent by ancestry, with the strongest signal for European ancestry (PMH: OR = 1.10, 95% CI: 1.08–1.12; EHR: OR = 1.07, 95% CI: 1.05–1.10). Associations between PRS and lifetime depression were largely consistent and significant associations varied minimally (ORs = 1.06–1.45) by state of residence in both subsamples.
Conclusions
Recorded depression prevalence by state in All of Us demonstrates a wide range, likely reflecting recruitment differences, EHR data completeness, and true geographic variation; yet PRS associations remained relatively stable. As studies like All of Us expand, accounting for sample composition and measurement approaches will be crucial for generating actionable findings.
Social connections might be protective against depressive and anxious symptoms and dementia in later life. The extent to which social connections are heritable versus modifiable in older age remains unknown.
Aims
We aimed to investigate the heritability of social connections and their influence on mental and cognitive health over time among older adults in a longitudinal cohort.
Method
We analysed data from the Older Australian Twins Study (333 monozygotic, 266 dizygotic twins; 65+ years) at three time-points over 6 years. We examined the factor structure and heritability of baseline social connections and their associations with mental and cognitive health longitudinally.
Results
We found three weakly heritable social connections factors: (a) interacting with friends/neighbours/community (h2 = 0.09, 95% CI: 0.00, 0.44); (b) family interactions/childcare (h2 = 0.13, 95% CI: 0.00, 0.43); (c) involvement in religious groups/caregiving (h2 = 0.00, 95% CI: 0.00, 0.19). Strong genetic correlations were observed between depressive symptoms and factors a (r = −0.96) and b (r = −0.60). More frequent baseline interactions with friends/neighbours/community were associated with fewer depressive symptoms cross-sectionally (B = −0.14, p = .004) and longitudinally (B = −0.09, p = 0.006), but the associations between social connections and cognitive health were not significant.
Conclusions
Social connections were weakly heritable, suggesting large environmental determination. Connections with friends/neighbours/community were associated with better mental health cross-sectionally and over time.
Dextro-transposition of the great arteries is a critical CHD traditionally considered sporadic, with low familial recurrence. Emerging evidence suggests a genetic component in select cases, particularly with rare familial clustering. We report concordant d-TGA in monochorionic diamniotic twins, a highly unusual occurrence, strengthening the argument for a heritable predisposition.
This position statement provides guidelines for health professionals who are considering online or direct-to-consumer genetic testing for their patients. It presents the major issues around online and direct-to-consumer (DTC) testing including how it is accessed, motivations for accessing testing and how to return these results. Online or DTC recommendations include: (1) DTC testing should only be done by individuals/consumers who are well informed, aware of the risks, benefits and limitations of testing, and able to consent for their DNA to be collected, analyzed and potentially stored. Where possible, individuals/consumers should also be aware of the alternative option of undertaking testing through healthcare professionals in a clinical context, and the benefits of this. (2) Decisions about having a child tested should be based on peer-reviewed, published evidence. Genomics testing for children should be within a clinical context where parents are informed, have access to clinical support and professional genetic counseling about this decision, as well as support for the range of results received. (3) Parents considering direct-to-consumer testing on their newborn are counselled, or given information, to encourage them to have standard government funded newborn bloodspot screening testing on their newborn. (4) When choosing an online genomic test, preference should be given to tests undertaken in accredited laboratories offering tests accredited with the Therapeutic Goods Administration. (5) Results obtained through methods other than direct analysis from a laboratory accredited to perform genomic testing to inform human health and wellbeing should be interpreted with caution. The HGSA recommends that such results must be confirmed in an accredited diagnostic laboratory prior to relying on them to inform options for treatment, surveillance or risk reduction, or before undertaking cascade testing in family members. (6) When individuals are concerned about their health, they should consult an appropriate healthcare professional to decide whether an online genomic test is appropriate and discuss how useful test results could be to make health-related decisions.
Posterior cortical atrophy (PCA) is a rare neurodegenerative syndrome primarily affecting the parietal and occipital lobes. It is characterized by early deficits in visuospatial processing, numeracy, and literacy. The most common underlying pathology is Alzheimer’s disease (AD). PCA typically presents as a young onset form of dementia, with the majority of patients aged 50–65 years. The clinical presentation of PCA includes difficulties with visually and spatially complex tasks. Neuropsychological features include impairments in visuospatial and visuoperceptual processing. Neuroimaging studies show occipito-parietal atrophy and hypometabolism . There is limited evidence of a genetic component in PCAs. Pathologically, PCA is most commonly associated with AD. The consensus classification of PCA provides a framework for improved diagnosis and research. PCA shows overlap with other atypical AD presentations, and there is heterogeneity within the syndrome. The impact of PCA on everyday abilities and the subjective experience of individuals with PCA is not well understood. Management and support for PCA include pharmacological and nonpharmacological approaches .
Corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP) are neurodegenerative diseases associated with tau protein abnormalities. CBD is characterized by asymmetric parkinsonism, apraxia, and cognitive and behavioral symptoms. PSP is characterized by supranuclear gaze palsy, postural instability, and cognitive and behavioral changes. Both diseases have heterogeneous clinical presentations and can be difficult to diagnose. There are currently no disease-modifying treatments available for CBD or PSP, but symptomatic relief can be provided through medications and therapy. Research is ongoing to develop biomarkers and therapies for these diseases.